Stem Cell Therapy Industry Research Report 2024
Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Bone marrow transplant is the most widely used stem-cell therapy, but some therapies derived from umbilical cord blood are also in use.
According to APO Research, The global Stem Cell Therapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North America is the largest Stem Cell Therapy market with about 65% market share. Europe is follower, accounting for about 16% market share.
The key players are Osiris Therapeutics, NuVasive, Chiesi Pharmaceuticals, JCR Pharmaceutical, Pharmicell, Medi-post, Anterogen, Molmed, Takeda (TiGenix) etc. Top 3 companies occupied about 38% market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Stem Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Stem Cell Therapy.
The Stem Cell Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Stem Cell Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Stem Cell Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Stem Cell Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Stem Cell Therapy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Stem Cell Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Chapter 13: The main points and conclusions of the report.
According to APO Research, The global Stem Cell Therapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North America is the largest Stem Cell Therapy market with about 65% market share. Europe is follower, accounting for about 16% market share.
The key players are Osiris Therapeutics, NuVasive, Chiesi Pharmaceuticals, JCR Pharmaceutical, Pharmicell, Medi-post, Anterogen, Molmed, Takeda (TiGenix) etc. Top 3 companies occupied about 38% market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Stem Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Stem Cell Therapy.
The Stem Cell Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Stem Cell Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Osiris Therapeutics
- NuVasive
- Chiesi Pharmaceuticals
- JCR Pharmaceutical
- Pharmicell
- Medi-post
- Anterogen
- Molmed
- Takeda (TiGenix)
- Autologous
- Allogeneic
- Musculoskeletal Disorder
- Wounds & Injuries
- Cornea
- Cardiovascular Diseases
- Others
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Stem Cell Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Stem Cell Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Stem Cell Therapy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Stem Cell Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Chapter 13: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Stem Cell Therapy by Type
2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
2.2.2 Autologous
2.2.3 Allogeneic
2.3 Stem Cell Therapy by Application
2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
2.3.2 Musculoskeletal Disorder
2.3.3 Wounds & Injuries
2.3.4 Cornea
2.3.5 Cardiovascular Diseases
2.3.6 Others
2.4 Assumptions and Limitations
3 STEM CELL THERAPY BREAKDOWN DATA BY TYPE
3.1 Global Stem Cell Therapy Historic Market Size by Type (2019-2024)
3.2 Global Stem Cell Therapy Forecasted Market Size by Type (2025-2030)
4 STEM CELL THERAPY BREAKDOWN DATA BY APPLICATION
4.1 Global Stem Cell Therapy Historic Market Size by Application (2019-2024)
4.2 Global Stem Cell Therapy Forecasted Market Size by Application (2019-2024)
5 GLOBAL GROWTH TRENDS
5.1 Global Stem Cell Therapy Market Perspective (2019-2030)
5.2 Global Stem Cell Therapy Growth Trends by Region
5.2.1 Global Stem Cell Therapy Market Size by Region: 2019 VS 2023 VS 2030
5.2.2 Stem Cell Therapy Historic Market Size by Region (2019-2024)
5.2.3 Stem Cell Therapy Forecasted Market Size by Region (2025-2030)
5.3 Stem Cell Therapy Market Dynamics
5.3.1 Stem Cell Therapy Industry Trends
5.3.2 Stem Cell Therapy Market Drivers
5.3.3 Stem Cell Therapy Market Challenges
5.3.4 Stem Cell Therapy Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Stem Cell Therapy Players by Revenue
6.1.1 Global Top Stem Cell Therapy Players by Revenue (2019-2024)
6.1.2 Global Stem Cell Therapy Revenue Market Share by Players (2019-2024)
6.2 Global Stem Cell Therapy Industry Players Ranking, 2022 VS 2023 VS 2024
6.3 Global Key Players of Stem Cell Therapy Head office and Area Served
6.4 Global Stem Cell Therapy Players, Product Type & Application
6.5 Global Stem Cell Therapy Players, Date of Enter into This Industry
6.6 Global Stem Cell Therapy Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Stem Cell Therapy Market Size (2019-2030)
7.2 North America Stem Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 North America Stem Cell Therapy Market Size by Country (2019-2024)
7.4 North America Stem Cell Therapy Market Size by Country (2025-2030)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Stem Cell Therapy Market Size (2019-2030)
8.2 Europe Stem Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Europe Stem Cell Therapy Market Size by Country (2019-2024)
8.4 Europe Stem Cell Therapy Market Size by Country (2025-2030)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Russia
8.10 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Stem Cell Therapy Market Size (2019-2030)
9.2 Asia-Pacific Stem Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Asia-Pacific Stem Cell Therapy Market Size by Country (2019-2024)
9.4 Asia-Pacific Stem Cell Therapy Market Size by Country (2025-2030)
9.5 China
9.6 Japan
9.7 South Korea
9.8 Southeast Asia
9.9 India
9.10 Australia
10 LATIN AMERICA
10.1 Latin America Stem Cell Therapy Market Size (2019-2030)
10.2 Latin America Stem Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Latin America Stem Cell Therapy Market Size by Country (2019-2024)
10.4 Latin America Stem Cell Therapy Market Size by Country (2025-2030)
10.5 Mexico
10.6 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Stem Cell Therapy Market Size (2019-2030)
11.2 Middle East & Africa Stem Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
11.3 Middle East & Africa Stem Cell Therapy Market Size by Country (2019-2024)
11.4 Middle East & Africa Stem Cell Therapy Market Size by Country (2025-2030)
11.5 Turkey
11.6 Saudi Arabia
11.7 UAE
12 PLAYERS PROFILED
12.1 Osiris Therapeutics
12.1.1 Osiris Therapeutics Company Information
12.1.2 Osiris Therapeutics Business Overview
12.1.3 Osiris Therapeutics Revenue in Stem Cell Therapy Business (2019-2024)
12.1.4 Osiris Therapeutics Stem Cell Therapy Product Portfolio
12.1.5 Osiris Therapeutics Recent Developments
12.2 NuVasive
12.2.1 NuVasive Company Information
12.2.2 NuVasive Business Overview
12.2.3 NuVasive Revenue in Stem Cell Therapy Business (2019-2024)
12.2.4 NuVasive Stem Cell Therapy Product Portfolio
12.2.5 NuVasive Recent Developments
12.3 Chiesi Pharmaceuticals
12.3.1 Chiesi Pharmaceuticals Company Information
12.3.2 Chiesi Pharmaceuticals Business Overview
12.3.3 Chiesi Pharmaceuticals Revenue in Stem Cell Therapy Business (2019-2024)
12.3.4 Chiesi Pharmaceuticals Stem Cell Therapy Product Portfolio
12.3.5 Chiesi Pharmaceuticals Recent Developments
12.4 JCR Pharmaceutical
12.4.1 JCR Pharmaceutical Company Information
12.4.2 JCR Pharmaceutical Business Overview
12.4.3 JCR Pharmaceutical Revenue in Stem Cell Therapy Business (2019-2024)
12.4.4 JCR Pharmaceutical Stem Cell Therapy Product Portfolio
12.4.5 JCR Pharmaceutical Recent Developments
12.5 Pharmicell
12.5.1 Pharmicell Company Information
12.5.2 Pharmicell Business Overview
12.5.3 Pharmicell Revenue in Stem Cell Therapy Business (2019-2024)
12.5.4 Pharmicell Stem Cell Therapy Product Portfolio
12.5.5 Pharmicell Recent Developments
12.6 Medi-post
12.6.1 Medi-post Company Information
12.6.2 Medi-post Business Overview
12.6.3 Medi-post Revenue in Stem Cell Therapy Business (2019-2024)
12.6.4 Medi-post Stem Cell Therapy Product Portfolio
12.6.5 Medi-post Recent Developments
12.7 Anterogen
12.7.1 Anterogen Company Information
12.7.2 Anterogen Business Overview
12.7.3 Anterogen Revenue in Stem Cell Therapy Business (2019-2024)
12.7.4 Anterogen Stem Cell Therapy Product Portfolio
12.7.5 Anterogen Recent Developments
12.8 Molmed
12.8.1 Molmed Company Information
12.8.2 Molmed Business Overview
12.8.3 Molmed Revenue in Stem Cell Therapy Business (2019-2024)
12.8.4 Molmed Stem Cell Therapy Product Portfolio
12.8.5 Molmed Recent Developments
12.9 Takeda (TiGenix)
12.9.1 Takeda (TiGenix) Company Information
12.9.2 Takeda (TiGenix) Business Overview
12.9.3 Takeda (TiGenix) Revenue in Stem Cell Therapy Business (2019-2024)
12.9.4 Takeda (TiGenix) Stem Cell Therapy Product Portfolio
12.9.5 Takeda (TiGenix) Recent Developments
13 REPORT CONCLUSION
14 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Stem Cell Therapy by Type
2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
2.2.2 Autologous
2.2.3 Allogeneic
2.3 Stem Cell Therapy by Application
2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
2.3.2 Musculoskeletal Disorder
2.3.3 Wounds & Injuries
2.3.4 Cornea
2.3.5 Cardiovascular Diseases
2.3.6 Others
2.4 Assumptions and Limitations
3 STEM CELL THERAPY BREAKDOWN DATA BY TYPE
3.1 Global Stem Cell Therapy Historic Market Size by Type (2019-2024)
3.2 Global Stem Cell Therapy Forecasted Market Size by Type (2025-2030)
4 STEM CELL THERAPY BREAKDOWN DATA BY APPLICATION
4.1 Global Stem Cell Therapy Historic Market Size by Application (2019-2024)
4.2 Global Stem Cell Therapy Forecasted Market Size by Application (2019-2024)
5 GLOBAL GROWTH TRENDS
5.1 Global Stem Cell Therapy Market Perspective (2019-2030)
5.2 Global Stem Cell Therapy Growth Trends by Region
5.2.1 Global Stem Cell Therapy Market Size by Region: 2019 VS 2023 VS 2030
5.2.2 Stem Cell Therapy Historic Market Size by Region (2019-2024)
5.2.3 Stem Cell Therapy Forecasted Market Size by Region (2025-2030)
5.3 Stem Cell Therapy Market Dynamics
5.3.1 Stem Cell Therapy Industry Trends
5.3.2 Stem Cell Therapy Market Drivers
5.3.3 Stem Cell Therapy Market Challenges
5.3.4 Stem Cell Therapy Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Stem Cell Therapy Players by Revenue
6.1.1 Global Top Stem Cell Therapy Players by Revenue (2019-2024)
6.1.2 Global Stem Cell Therapy Revenue Market Share by Players (2019-2024)
6.2 Global Stem Cell Therapy Industry Players Ranking, 2022 VS 2023 VS 2024
6.3 Global Key Players of Stem Cell Therapy Head office and Area Served
6.4 Global Stem Cell Therapy Players, Product Type & Application
6.5 Global Stem Cell Therapy Players, Date of Enter into This Industry
6.6 Global Stem Cell Therapy Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Stem Cell Therapy Market Size (2019-2030)
7.2 North America Stem Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 North America Stem Cell Therapy Market Size by Country (2019-2024)
7.4 North America Stem Cell Therapy Market Size by Country (2025-2030)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Stem Cell Therapy Market Size (2019-2030)
8.2 Europe Stem Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Europe Stem Cell Therapy Market Size by Country (2019-2024)
8.4 Europe Stem Cell Therapy Market Size by Country (2025-2030)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Russia
8.10 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Stem Cell Therapy Market Size (2019-2030)
9.2 Asia-Pacific Stem Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Asia-Pacific Stem Cell Therapy Market Size by Country (2019-2024)
9.4 Asia-Pacific Stem Cell Therapy Market Size by Country (2025-2030)
9.5 China
9.6 Japan
9.7 South Korea
9.8 Southeast Asia
9.9 India
9.10 Australia
10 LATIN AMERICA
10.1 Latin America Stem Cell Therapy Market Size (2019-2030)
10.2 Latin America Stem Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Latin America Stem Cell Therapy Market Size by Country (2019-2024)
10.4 Latin America Stem Cell Therapy Market Size by Country (2025-2030)
10.5 Mexico
10.6 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Stem Cell Therapy Market Size (2019-2030)
11.2 Middle East & Africa Stem Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
11.3 Middle East & Africa Stem Cell Therapy Market Size by Country (2019-2024)
11.4 Middle East & Africa Stem Cell Therapy Market Size by Country (2025-2030)
11.5 Turkey
11.6 Saudi Arabia
11.7 UAE
12 PLAYERS PROFILED
12.1 Osiris Therapeutics
12.1.1 Osiris Therapeutics Company Information
12.1.2 Osiris Therapeutics Business Overview
12.1.3 Osiris Therapeutics Revenue in Stem Cell Therapy Business (2019-2024)
12.1.4 Osiris Therapeutics Stem Cell Therapy Product Portfolio
12.1.5 Osiris Therapeutics Recent Developments
12.2 NuVasive
12.2.1 NuVasive Company Information
12.2.2 NuVasive Business Overview
12.2.3 NuVasive Revenue in Stem Cell Therapy Business (2019-2024)
12.2.4 NuVasive Stem Cell Therapy Product Portfolio
12.2.5 NuVasive Recent Developments
12.3 Chiesi Pharmaceuticals
12.3.1 Chiesi Pharmaceuticals Company Information
12.3.2 Chiesi Pharmaceuticals Business Overview
12.3.3 Chiesi Pharmaceuticals Revenue in Stem Cell Therapy Business (2019-2024)
12.3.4 Chiesi Pharmaceuticals Stem Cell Therapy Product Portfolio
12.3.5 Chiesi Pharmaceuticals Recent Developments
12.4 JCR Pharmaceutical
12.4.1 JCR Pharmaceutical Company Information
12.4.2 JCR Pharmaceutical Business Overview
12.4.3 JCR Pharmaceutical Revenue in Stem Cell Therapy Business (2019-2024)
12.4.4 JCR Pharmaceutical Stem Cell Therapy Product Portfolio
12.4.5 JCR Pharmaceutical Recent Developments
12.5 Pharmicell
12.5.1 Pharmicell Company Information
12.5.2 Pharmicell Business Overview
12.5.3 Pharmicell Revenue in Stem Cell Therapy Business (2019-2024)
12.5.4 Pharmicell Stem Cell Therapy Product Portfolio
12.5.5 Pharmicell Recent Developments
12.6 Medi-post
12.6.1 Medi-post Company Information
12.6.2 Medi-post Business Overview
12.6.3 Medi-post Revenue in Stem Cell Therapy Business (2019-2024)
12.6.4 Medi-post Stem Cell Therapy Product Portfolio
12.6.5 Medi-post Recent Developments
12.7 Anterogen
12.7.1 Anterogen Company Information
12.7.2 Anterogen Business Overview
12.7.3 Anterogen Revenue in Stem Cell Therapy Business (2019-2024)
12.7.4 Anterogen Stem Cell Therapy Product Portfolio
12.7.5 Anterogen Recent Developments
12.8 Molmed
12.8.1 Molmed Company Information
12.8.2 Molmed Business Overview
12.8.3 Molmed Revenue in Stem Cell Therapy Business (2019-2024)
12.8.4 Molmed Stem Cell Therapy Product Portfolio
12.8.5 Molmed Recent Developments
12.9 Takeda (TiGenix)
12.9.1 Takeda (TiGenix) Company Information
12.9.2 Takeda (TiGenix) Business Overview
12.9.3 Takeda (TiGenix) Revenue in Stem Cell Therapy Business (2019-2024)
12.9.4 Takeda (TiGenix) Stem Cell Therapy Product Portfolio
12.9.5 Takeda (TiGenix) Recent Developments
13 REPORT CONCLUSION
14 DISCLAIMER
